Summit Therapeutics SMMT
NASDAQ SMMT
$17.60 +0.48 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) FCF Margin (QoQ) (2017 - 2022)

Analysis

Summit Therapeutics (SMMT) FCF Margin (QoQ) (2017 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Summit Therapeutics 13.67 Bn 12.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 442,258.00
Jun 30, 2022 -55,733.00
Mar 31, 2022 -404,002.00
Dec 31, 2021 -190,486.00
Sep 30, 2021 3.21 Mn
Jun 30, 2021 -2.31 Mn
Mar 31, 2021 -644,974.00
Dec 31, 2020 497,979.00
Sep 30, 2020 166,159.00
Jun 30, 2020 -831,600.00
Mar 31, 2020 -1.02 Mn
Oct 31, 2018 -61,141.00
Jul 31, 2018 15,458.00
Oct 31, 2017 -59,648.00
Jul 31, 2017 67,477.00